Enrollment exceeding expectations in DURAVYU™ Phase 3 wet AMD clinical trials with LUGANO over 50% enrolled and LUCIA recruiting ahead of schedule – – Positive Phase 2 VERONA clinical trial of DURAVYU ...
The S&P/ASX 200 Health Care Index fell 7.66% in February. Morgans healthcare analyst Iain Wilkie noted several factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback